Bryan M. Gillard

17.4k total citations
25 papers, 615 citations indexed

About

Bryan M. Gillard is a scholar working on Molecular Biology, Pulmonary and Respiratory Medicine and Oncology. According to data from OpenAlex, Bryan M. Gillard has authored 25 papers receiving a total of 615 indexed citations (citations by other indexed papers that have themselves been cited), including 20 papers in Molecular Biology, 10 papers in Pulmonary and Respiratory Medicine and 5 papers in Oncology. Recurrent topics in Bryan M. Gillard's work include Epigenetics and DNA Methylation (9 papers), Prostate Cancer Treatment and Research (9 papers) and RNA modifications and cancer (3 papers). Bryan M. Gillard is often cited by papers focused on Epigenetics and DNA Methylation (9 papers), Prostate Cancer Treatment and Research (9 papers) and RNA modifications and cancer (3 papers). Bryan M. Gillard collaborates with scholars based in United States, Italy and China. Bryan M. Gillard's co-authors include Barbara A. Foster, Ellen Karasik, Donald L. Trump, Mukund Seshadri, Candace S. Johnson, Weidong Yu, Ivy Chung, Guangzhou Han, Michael T. Moser and Dominic J. Smiraglia and has published in prestigious journals such as Nature Communications, PLoS ONE and Cancer Research.

In The Last Decade

Bryan M. Gillard

25 papers receiving 608 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Bryan M. Gillard United States	12	320	151	137	124	111	25	615
Elżbieta Gocek Poland	15	458 1.4×	223 1.5×	123 0.9×	46 0.4×	156 1.4×	20	757
Núria Eritja Spain	18	449 1.4×	108 0.7×	191 1.4×	63 0.5×	202 1.8×	40	768
Demao Yao China	11	373 1.2×	115 0.8×	101 0.7×	122 1.0×	171 1.5×	13	579
Hong Yi China	11	423 1.3×	164 1.1×	205 1.5×	74 0.6×	165 1.5×	22	671
LaMonica V. Stewart United States	17	477 1.5×	180 1.2×	156 1.1×	172 1.4×	207 1.9×	28	793
Jeong‐Hun Ko United Kingdom	14	467 1.5×	53 0.4×	131 1.0×	157 1.3×	100 0.9×	23	781
Xianghuai Lu United States	11	396 1.2×	54 0.4×	130 0.9×	97 0.8×	104 0.9×	11	706
Abdullah Ekmekçi Türkiye	16	285 0.9×	68 0.5×	130 0.9×	72 0.6×	167 1.5×	37	580
Helge Lind Norway	9	607 1.9×	109 0.7×	250 1.8×	93 0.8×	233 2.1×	9	810
Lucia D’Antona Italy	17	436 1.4×	65 0.4×	108 0.8×	47 0.4×	139 1.3×	30	748

Countries citing papers authored by Bryan M. Gillard

Since Specialization

Citations

This map shows the geographic impact of Bryan M. Gillard's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Bryan M. Gillard with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Bryan M. Gillard more than expected).

Fields of papers citing papers by Bryan M. Gillard

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Bryan M. Gillard. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Bryan M. Gillard. The network helps show where Bryan M. Gillard may publish in the future.

Co-authorship network of co-authors of Bryan M. Gillard

This figure shows the co-authorship network connecting the top 25 collaborators of Bryan M. Gillard. A scholar is included among the top collaborators of Bryan M. Gillard based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Bryan M. Gillard. Bryan M. Gillard is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Gillard, Bryan M., Tao Dai, Andrew Fisher, et al.. (2025). Inosine monophosphate dehydrogenase 2 (IMPDH2) modulates response to therapy and chemo-resistance in triple negative breast cancer. Scientific Reports. 15(1). 1061–1061. 4 indexed citations

Melendy, Thomas, Robert M. Straubinger, Bryan M. Gillard, et al.. (2024). A synergistic two-drug therapy specifically targets a DNA repair dysregulation that occurs in p53-deficient colorectal and pancreatic cancers. Cell Reports Medicine. 5(3). 101434–101434. 6 indexed citations

Gillard, Bryan M., Ellen Karasik, Edward Hurley, et al.. (2023). Aryl hydrocarbon receptor is a tumor promoter in MYCN-amplified neuroblastoma cells through suppression of differentiation. iScience. 26(11). 108303–108303. 8 indexed citations

Gillard, Bryan M., Michelle Wrobel, Ellen Karasik, et al.. (2023). Syngeneic model of carcinogen-induced tumor mimics basal/squamous, stromal-rich, and neuroendocrine molecular and immunological features of muscle-invasive bladder cancer. Frontiers in Oncology. 13. 1120329–1120329. 4 indexed citations

Want, Muzamil Y., Ellen Karasik, Bryan M. Gillard, AJ Robert McGray, & Sebastiano Battaglia. (2021). Inhibition of WHSC1 Allows for Reprogramming of the Immune Compartment in Prostate Cancer. International Journal of Molecular Sciences. 22(16). 8742–8742. 8 indexed citations

Want, Muzamil Y., Takemasa Tsuji, Prashant Kumar Singh, et al.. (2021). WHSC1/NSD2 regulates immune infiltration in prostate cancer. Journal for ImmunoTherapy of Cancer. 9(2). e001374–e001374. 27 indexed citations

Affronti, Hayley C., Aryn M. Rowsam, Spencer R. Rosario, et al.. (2020). Pharmacological polyamine catabolism upregulation with methionine salvage pathway inhibition as an effective prostate cancer therapy. Nature Communications. 11(1). 52–52. 46 indexed citations

Mett, Vadim, Elena A. Komarova, Ivan A. Bespalov, et al.. (2017). Mobilan: a recombinant adenovirus carrying Toll-like receptor 5 self-activating cassette for cancer immunotherapy. Oncogene. 37(4). 439–449. 33 indexed citations

Battaglia, Sebastiano, Ellen Karasik, Bryan M. Gillard, et al.. (2017). LSD1 dual function in mediating epigenetic corruption of the vitamin D signaling in prostate cancer. Clinical Epigenetics. 9(1). 82–82. 18 indexed citations

10.

Affronti, Hayley C., Mark D. Long, Spencer R. Rosario, et al.. (2017). Dietary folate levels alter the kinetics and molecular mechanism of prostate cancer recurrence in the CWR22 model. Oncotarget. 8(61). 103758–103774. 11 indexed citations

11.

Bistulfi, Gaia, Hayley C. Affronti, Barbara A. Foster, et al.. (2016). The essential role of methylthioadenosine phosphorylase in prostate cancer. Oncotarget. 7(12). 14380–14393. 31 indexed citations

12.

Drummond, Daryl C., Michael T. Moser, Walid S. Kamoun, et al.. (2016). Abstract 2069: Activity of an EphA2-targeted docetaxel nanoliposome in pancreatic patient-derived models as monotherapy and in combination with gemcitabine. Cancer Research. 76(14_Supplement). 2069–2069. 1 indexed citations

13.

Kirk, Jason, Ellen Karasik, Bryan M. Gillard, et al.. (2014). Early Growth Inhibition Is Followed by Increased Metastatic Disease with Vitamin D (Calcitriol) Treatment in the TRAMP Model of Prostate Cancer. PLoS ONE. 9(2). e89555–e89555. 26 indexed citations

14.

Miles, Kiersten Marie, Mukund Seshadri, Eric Ciamporcero, et al.. (2014). Dll4 Blockade Potentiates the Anti-Tumor Effects of VEGF Inhibition in Renal Cell Carcinoma Patient-Derived Xenografts. PLoS ONE. 9(11). e112371–e112371. 47 indexed citations

15.

Su, Bing, Lingqiu Gao, Catherine Baranowski, et al.. (2014). A Genome-Wide RNAi Screen Identifies FOXO4 as a Metastasis-Suppressor through Counteracting PI3K/AKT Signal Pathway in Prostate Cancer. PLoS ONE. 9(7). e101411–e101411. 45 indexed citations

16.

Su, Bing, Bryan M. Gillard, Lingqiu Gao, Kevin H. Eng, & Irwin H. Gelman. (2013). Src controls castration recurrence of CWR22 prostate cancer xenografts. Cancer Medicine. 2(6). 784–792. 10 indexed citations

17.

Barthel, Steven R., Matthew Opperman, Kempland C. Walley, et al.. (2012). Definition of Molecular Determinants of Prostate Cancer Cell Bone Extravasation. Cancer Research. 73(2). 942–952. 60 indexed citations

18.

Bistulfi, Gaia, Barbara A. Foster, Ellen Karasik, et al.. (2011). Dietary Folate Deficiency Blocks Prostate Cancer Progression in the TRAMP Model. Cancer Prevention Research. 4(11). 1825–1834. 35 indexed citations

19.

Kinney, Shannon R. Morey, Wa Zhang, Marién Pascual, et al.. (2009). Lack of Evidence for Green Tea Polyphenols as DNA Methylation Inhibitors in Murine Prostate. Cancer Prevention Research. 2(12). 1065–1075. 31 indexed citations

20.

Chung, Ivy, Guangzhou Han, Mukund Seshadri, et al.. (2009). Role of Vitamin D Receptor in the Antiproliferative Effects of Calcitriol in Tumor-Derived Endothelial Cells and Tumor Angiogenesis In vivo. Cancer Research. 69(3). 967–975. 142 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact